Combating Drug Abuse: India’s Narcotic Drugs and Psychotropic Substances Policy

Walk past any college canteen, urban bus stop, or rave-adjacent music festival, and you will hear whispers of a quiet crisis. Drug addiction is no longer a problem lurking in distant red-light districts or remote border towns; it has made its way into hostels, housing societies, and even school bags. To respond to this creeping menace, the government crafted a dedicated framework, the National Policy on Narcotic Drugs and Psychotropic Substances (NDPS), that ties together law, health, education, and social welfare into one coordinated plan.

Why a dedicated policy was needed 🔗

Drug abuse in the country has grown into a full-blown public health emergency, and the numbers tell the story bluntly. The National Survey on Extent and Pattern of Substance Use in India, conducted by the Ministry of Social Justice and Empowerment through AIIMS in 2018, found that around 6.06 per cent of children aged 10 to 17 and 24.71 per cent of adults between 18 and 75 were indulging in some form of substance use. More recent data placed in Parliament estimates roughly 29 million cannabis users, 19 million opioid users, and 11 million sedative users in the 18 to 75 age group.

The problem is particularly acute among the youth. A large majority of drug users begin substance abuse before the age of 19, with many starting between the ages of 16 and 20. Academic stress, peer pressure, unemployment, glamorisation of drugs in popular media, and easy availability through porous borders have all accelerated the slide. Add to this the geography: the country sits uncomfortably between the “Golden Crescent” of Afghanistan, Pakistan, and Iran, and the “Golden Triangle” of Myanmar, Laos, and Thailand, two of the world’s largest opium-producing belts. A purely law-and-order approach was never going to be enough.

The legal backbone: NDPS Act, 1985 🔗

Before we get to the policy itself, it helps to understand the law it sits on top of. The Narcotic Drugs and Psychotropic Substances Act was passed by Parliament in 1985 and came into force on 14 November 1985, giving effect to the country’s treaty obligations under the three major UN drug conventions. It prohibits the production, manufacture, cultivation, possession, sale, purchase, transport, storage, and consumption of any narcotic or psychotropic substance except for medical or scientific purposes.

The Act has a wide reach. It applies across the country and extends to all Indian citizens outside the country and to persons on ships and aircraft registered in India. It has also been amended four times, in 1988, 2001, 2014, and 2021, to plug loopholes and adapt to new realities such as the rise of synthetic drugs and the need for palliative care access.

Constitutional grounding 🔗

The policy and the Act both trace their authority back to the Constitution. Article 47 directs the State to endeavour to bring about prohibition of the consumption, except for medicinal purposes, of intoxicating drugs injurious to health. This Directive Principle, read with the country’s ratification of the Single Convention on Narcotic Drugs, 1961, the Convention on Psychotropic Substances, 1971, and the UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988, forms the legal and moral bedrock of the entire regulatory framework.

The National Policy on NDPS, 2012 🔗

For nearly three decades after the NDPS Act came into force, the country relied almost entirely on legislation and scattered schemes to respond to addiction. A consolidated, written policy was missing. This gap was filled in 2012, when the Ministry of Finance introduced the National Policy on Narcotic Drugs and Psychotropic Substances.

The policy was drafted to guide various ministries and departments, state governments, international organisations, and NGOs, and to reassert the country’s commitment to combat the drug menace holistically. In essence, it is a common rulebook for everyone involved, from a customs officer at an international airport to a counsellor at a de-addiction clinic in a small district hospital.

The three pillars of the policy 🔗

The NDPS Policy takes a three-pronged approach that mirrors global best practice. The stakeholders engage in three broad approaches to implement the policy: supply reduction, demand reduction, and harm reduction.

Supply reduction focuses on choking the availability of illicit drugs through enforcement, seizure, and regulation of precursor chemicals. It is primarily driven by central and state agencies such as the Department of Revenue under the Ministry of Finance, the Narcotics Control Bureau, the Central Bureau of Narcotics, the Central Economic Intelligence Bureau, and state police and excise departments.

Demand reduction is about preventing people, especially the young, from turning to drugs in the first place and supporting those who already have. The demand reduction sector works on prevention, early identification, treatment, and rehabilitation of those with drug-related problems, with the Ministry of Social Justice and Empowerment serving as the nodal ministry.

Harm reduction seeks to minimise the medical and social damage drug use causes, for example, by preventing the spread of HIV among injecting drug users through needle exchange and opioid substitution therapy. This arm is mostly steered by the health sector.

Who does what: a map of responsibilities 🔗

One of the most practical contributions of the 2012 policy is that it clearly divides responsibilities across multiple ministries so that agencies don’t step on each other’s toes or, worse, leave gaps. Under the Allocation of Business Rules, the NDPS Act is administered by the Ministry of Finance, Department of Revenue, while matters pertaining to drug demand reduction are handled by the Ministry of Social Justice and Empowerment.

Key enforcement agencies 🔗

On the enforcement side, the Narcotics Control Bureau serves as the apex coordinating agency for drug law enforcement, focusing primarily on inter-state and international drug trafficking, while state police act as the primary enforcement bodies at the local level. The Narco-Coordination Centre, or NCORD, under the Ministry of Home Affairs facilitates coordination among these agencies, ensuring that intelligence on, say, a consignment of heroin moving from Punjab to Gujarat doesn’t fall through the cracks.

Health and social welfare role 🔗

The Ministry of Health and Family Welfare runs de-addiction centres in government hospitals, while the Ministry of Social Justice and Empowerment supports voluntary organisations that run community-level programmes. The Drug Division within the Department of Social Justice and Empowerment releases grants-in-aid to NGOs for identification, counselling, treatment, and rehabilitation of addicts.

From policy to action: the NAPDDR 🔗

A policy on paper means little without a delivery vehicle. For effective implementation of the NDPS Policy 2012, the government designed the National Action Plan for Drug Demand Reduction (NAPDDR), currently running for the period 2018 to 2025.

Under NAPDDR, the government supports a network of service centres spread across the country. The Ministry supports 342 Integrated Rehabilitation Centres for Addicts (IRCAs), which provide preventive education, awareness generation, motivational counselling, detoxification, after-care, and social reintegration. It has also set up 45 District De-Addiction Centres in districts where no IRCA, Outreach and Drop-In Centre, or Community-based Peer Led Intervention centre exists.

Nasha Mukt Bharat Abhiyaan 🔗

Perhaps the most visible offshoot of the policy is the Nasha Mukt Bharat Abhiyaan, launched in August 2020. Initially rolled out in 272 of the most vulnerable districts and later extended to all districts, the Abhiyaan has reached more than 10.72 crore people, including 3.38 crore youth and 2.28 crore women, through over 8,000 youth volunteers. Schools and colleges are central to this mission, with more than 3.28 lakh educational institutions participating in the campaign.

Balancing strict enforcement with medical access 🔗

The NDPS Policy isn’t only about banning substances. It also recognises that opioids such as morphine are essential for cancer pain relief and palliative care, and that over-regulation had made these drugs nearly unavailable to patients who desperately needed them.

The 2014 amendment relaxed restrictions on Essential Narcotic Drugs such as morphine, fentanyl, and methadone, making them more accessible for pain relief and palliative care. Under this framework, a single agency, the state drug controller, can approve recognised medical institutions for stocking and dispensing these drugs, without the need for multiple separate licences.

This dual commitment, keeping drugs out of the hands of traffickers while keeping them within reach of doctors and patients, is one of the most delicate balancing acts in public administration.

Where the policy is still struggling 🔗

Honesty demands acknowledging that the system is far from perfect. Researchers have pointed out that the policy as currently implemented emphasises law enforcement as the primary solution to substance abuse, and the current mechanisms and infrastructure are more regulatory than preventive. The demand and harm reduction arms, though crucial, are often under-resourced.

The treatment gap is also glaring. The treatment-seeking rate hovers around 25 per cent among those with drug dependence, and hospital admission rates for treatment are even lower, at around 5 per cent. Stigma, shortage of trained counsellors, and patchy coverage in rural areas keep most addicts out of the formal care system.

Emerging challenges 🔗

Newer threats are also testing the policy. The rise of synthetic drugs, online drug marketplaces, and designer psychoactive substances mean that the list of banned chemicals is always playing catch-up with chemists. The policy’s supply-side framework was built primarily for plant-based drugs like opium and cannabis, and updating it for the synthetic era is an ongoing challenge.

The road ahead 🔗

A maturing drug policy has to do several things at once: keep law enforcement sharp, scale up affordable treatment, invest in prevention in schools and colleges, and treat addiction as a health condition rather than a moral failing. The NDPS Policy of 2012 laid the scaffolding for exactly this kind of holistic response, and later initiatives such as NAPDDR and Nasha Mukt Bharat Abhiyaan are steadily adding flesh to that skeleton.

What the country genuinely needs now is consistent funding, better data collection (the last major national survey was in 2018), and a cultural shift that lets young people ask for help without fear. Schools, parents, doctors, police officers, and civil society organisations each hold a piece of the solution. The policy simply hands them the same map.

What do you think? Should the approach to personal drug use be decriminalised and treated as a public health concern rather than a criminal one? And how can schools and colleges play a more meaningful role in prevention, without stigmatising students who are already struggling with addiction?

References

1. https://socialjustice.gov.in/writereaddata/UploadFile/Survey%20Report.pdf
2. https://lokbhavan.haryana.gov.in/publication/lets-come-together-to-prevent-drug-abuse/
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC12118791/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC12430855/
5. https://en.wikipedia.org/wiki/Narcotic_Drugs_and_Psychotropic_Substances_Act,_1985
6. https://narcoticsindia.nic.in/
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC10958082/
8. https://narcoticsindia.nic.in/Notifications/National_Policy_on_NDPS_published.pdf
9. https://en.wikipedia.org/wiki/Drug_policy_of_India
10. https://socialjustice.gov.in/common/76747
11. https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=1985911
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC12131045/